US EditionPublished • loading... • Updated
Medicare enrollees to pay 50% less for some drugs in 2025, report says
Medicare beneficiaries will see out-of-pocket costs drop nearly 50% for 10 drugs treating chronic conditions, saving an estimated $1.5 billion in 2026, according to CMS and AARP.
- New abilities for Medicare to negotiate prescription prices mean certain drugs should be 50% to 70% cheaper for many people in Florida, California, New York, Pennsylvania and Texas in 2026.
- The AARP attributes those savings to a law signed by former President Joe Biden in 2022 that requires Medicare to negotiate lower prices on behalf of beneficiaries.
- The law also stops price gouging by requiring rebates when companies raise prices faster than inflation, caps insulin at $35 per month for Medicare enrollees, and limits out-of-pocket prescription costs.
Insights by Ground AI
15 Articles
15 Articles
A recent study by the American Association of Retirees (AARP) shows that Medicare participants will see an average decrease of nearly 50% in out-of-pocket expenses for the first 10 negotiated drugs by 2026. This reflects the anticipated outcomes of Medicare Drug Price Negotiations under the Inflation Reduction Act...
Coverage Details
Total News Sources15
Leaning Left1Leaning Right2Center10Last UpdatedBias Distribution77% Center
Bias Distribution
- 77% of the sources are Center
77% Center
C 77%
15%
Factuality
To view factuality data please Upgrade to Premium
